Join
Live feed
·
INSIDERFilingvia Quantisnow
G1 Therapeutics Inc. logo

Chief Operating Officer Murdock Terry L was granted 17,900 shares and returned 124,762 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GTHX· G1 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GTHX (G1 Therapeutics Inc.) and more on Quantisnow.

Chief Operating Officer Murdock Terry L was granted 17,900 shares and returned 124,762 shares to the company, closing all direct ownership in the company (SEC Form 4) | Quantisnow